Levy RI: Review: Declining mortality in coronary heart disease. Arteriosclerosis1:312, 1981
2.
Kannel WB, Castelli WP, Gordon T., et al: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann Intern Med74:1-12, 1971
3.
Castelli WP: Epidemiology of coronary heart disease: The Framingham Study. Amer J Med76:4-12, 1984
4.
Goldstein JL , Kita T., Brown MS: Defective lipoprotein receptors and atherosclerosis. Lessons from the animal counterpart of familial hypercholesterolemia. N Engl J Med309:288-296, 1983
5.
Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science232:34-47, 1986
6.
Enos WF, Holmes RH, Beyer J.: Coronary disease among United States soldiers killed in action in Korea. Preliminary report. JAMA152:1090-1093, 1953
7.
Strong JP, Solberg LA, Restrepo C.: Atherosclerosis in persons with coronary heart disease. Lab Invest18:527-537, 1968
8.
Solberg LA, Enger SC, Hjermann I., et al: Risk factors for coronary and cerebral atherosclerosis in the Oslo Study, in Goto AM, Jr, Smith LC, Allen B (eds): Atherosclerosis VNew York, Springer-Verlag, 1980, pp 57-62
9.
Solberg LA, Strong JP: Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis3:187-198, 1983
10.
Faggiotto A., Ross R., Harker L.: Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis4:323-340, 1984 11. Faggiotto A., Ross R.: Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis4:341-356, 1984
11.
Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events. Final report. J Chronic Dis31:201-306, 1978
12.
Kagan A., Gordon T., Rhoads GG, et al: Some factors related to coronary heart disease incidence in Honolulu Japanese men: The Honolulu Heart Study. Int J Epidemiol4:271-279, 1975
13.
Martin MJ, Hulley SB, Browner WS, et al: Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361,662 men. Lancet2:933-936, 1986
14.
Kannel WB, Neaton JD, Wentworth D., et al: Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for MRFIT. Am Heart J112:825-836, 1986
15.
Castelli WP , Garrison RJ, Wilson Pwf, et al: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA256:2835-2838, 1986
16.
Robertson TL , Kato H., Rhoads GG, et al: Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol39:239-243, 1977
17.
Robertson TL , Kato H., Gordon T., et al: Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Coronary heart disease risk factors in Japan and Hawaii. Am J Cardiol39:244-249, 1977
18.
The Lipid Research Clinics primary prevention trial results. I. Reduction in incidence of coronary heart disease. JAMA251:351-364, 1984
19.
The Lipid Research Clinics primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA251:365-374, 1984
20.
Frick MH, Elo O., Haapa K., et al: Helsinki Heart Study: Primary-Prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med317:1237-1245, 1987
21.
Blankenhorn DH, Nessim SA, Johnson RL, et al: Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA257:3233-3240, 1987.
22.
Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med148:36-69, 1988